<DOC>
	<DOCNO>NCT02682446</DOCNO>
	<brief_summary>After endoscopic resection early gastric cancer ( EGC ) , remain concerned development metachronous gastric neoplasm ( MGN ) . The aim study evaluate role H. pylorus eradication reduce MGN ESD efficacy serum pepsinogen ( PG ) predict development MGN endoscopic submucosal dissection ( ESD ) EGC evaluate risk factor incidence MGN . The investigator enrol participant test serum PG I II time ESD EGC , January 2007 May 2013 single tertiary center , retrospectively . The baseline characteristic participant , H. pylorus status , serum pepsinogen analyze development MGN .</brief_summary>
	<brief_title>The Efficacy Serum Pepsinogen Prediction Metachronous Gastric Neoplasm</brief_title>
	<detailed_description />
	<mesh_term>Stomach Neoplasms</mesh_term>
	<criteria>The patient test serum PG concentration test H. pylorus status time ESD reveal pathologically complete en bloc resection ESD EGC . previous history ER ; prove pathologically incomplete resection lymphovascular invasion resect ESD specimen ; additional treatment ESD ; followup loss le 2 year .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>February 2016</verification_date>
	<keyword>Early gastric cancer</keyword>
	<keyword>endoscopic submucosal dissection</keyword>
	<keyword>serum pepsinogen</keyword>
	<keyword>Helicobacter pylorus</keyword>
</DOC>